On Monday, the Appellate Board upheld the compulsory licence granted to domestic firm Natco Pharma last year, against Bayer's patented anti-cancer drug Nexavar.
The panel of representatives from various ministries and chaired by B K Singh, director, department of pharmaceuticals, has suggested the government negotiate prices of patented medicines based on reference prices of such drugs in other countries such as Britain, Canada, France, Australia and New Zealand.
While the office of the Drugs Controller General of India is still struggling to accumulate data, compensation had been paid only in 50 per cent of the clinical trial death cases so far, sources said.
Companies run till now by mostly their promoters are increasingly inducting professionals to head their teams.
Finance Minister P Chidambaram is banking on the aspirations of people to own a swanky new mobile phone to boost the government's indirect tax revenue in the next financial year.
Charge relates to misuse of dominant position to sell spare parts at high rates.
Tribunal ruling in I-T's favour may open floodgates to claims against other MNCs.
The production of durable products (refrigerators, washing machines, air conditioners and conventional television sets) is contracting in India, according to new data released last week.
The last one year has been hectic for Dutch major Philips.
No ethics committee shall review and accord its approval to a clinical trial protocol without prior registration with the licensing authority, as defined in clause (b) of rule 21.
Harpreet Singh Tibb has worked at the largest fast-moving consumer goods company in the country, Hindustan Unilever.
As urban shoppers tighten their belts, companies are betting on rural consumers and smaller packs to fire up sales.
The attempt is to maximise revenues at a time when advertisers are increasingly demanding greater bang for the buck.
Disappointed with past experience, domestic majors even skip giving any memorandum.
Telcos likely to get to switch from 2,300-MHz band for 4G services.
Regulator mentions Wockhardt as manufacturer but firm says it only markets drug.
In January, consumer price index-based inflation rose for the fourth consecutive month. It stood at 10.78 per cent, against 10.56 per cent in December.
The patent office said Pfizer's claimed patent for Sutent, a cancer drug, did not involve any inventive step.
Health & family welfare ministry's proposal seeks to restrict sale of antibiotics to check self-medication.
Prodded by patent cliff & increasing competition, it files application for foray into injectible oncology segment.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances